We are international
Donate
publications TEXT SIZE   
general information

Phase I Study of BB-10901 (huN901-DM1) in Patients with Relapsed/Refractory CD56-Positive Myeloma
By Asher A. Chanan-Khan, MD
12.18.06
Phase I Study of BB-10901 (huN901-DM1) in Patients with Relapsed/Refractory CD56-Positive Myeloma



 related articles